GreenLight Biosciences Holdings, PBC, trading under the ticker ENVI, is the post-de-SPAC entity formed through the business combination of Environmental Impact Acquisition Corp and RNA therapeutics developer GreenLight Biosciences. Environmental Impact Acquisition Corp completed its blank-check IPO in 2021 with a stated focus on sustainability and environmental-impact investing before executing a transaction in the biotech and life-sciences sector. The combined company, GreenLight Biosciences Holdings, filed an 8-K with the SEC on July 24, 2023, reflecting ongoing post-merger corporate reporting obligations as the firm navigated its position in the RNA-based medicines industry. Visit SpacDesk to access the full filing record, sponsor details, and deal analytics for ENVI and hundreds of other SPAC transactions.